{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:36:05Z","timestamp":1787564165001,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":136,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.rmcr.2021.101432","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T01:10:12Z","timestamp":1621386612000},"page":"101432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sj\u00f6gren syndrome"],"prefix":"10.1016","volume":"33","author":[{"given":"Kirill","family":"Lipatov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-1719","authenticated-orcid":false,"given":"Aahd F.","family":"Kubbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Weerheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-977X","authenticated-orcid":false,"given":"Dante N.","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbah","family":"Baqir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmcr.2021.101432_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","article-title":"Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients","volume":"81","author":"Garcia-Carrasco","year":"2002","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.rmcr.2021.101432_bib2","first-page":"97","article-title":"Primary sjogren's syndrome","volume":"379","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2021.101432_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"Sjogren's Syndrome Criteria Working, 2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.rmcr.2021.101432_bib4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.rmed.2011.08.009","article-title":"Small airway disease associated with Sjogren's syndrome: clinico-pathological correlations","volume":"105","author":"Nakanishi","year":"2011","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101432_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/RHU.0000000000000771","article-title":"Constrictive bronchiolitis in patients with primary sjogren syndrome","volume":"25","author":"Wight","year":"2019","journal-title":"J. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.rmcr.2021.101432_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ccm.2019.05.002","article-title":"Pulmonary involvement in sjogren syndrome","volume":"40","author":"Natalini","year":"2019","journal-title":"Clin. Chest Med."},{"issue":"140","key":"10.1016\/j.rmcr.2021.101432_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sjogren's syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101432_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.88.2.226","article-title":"Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study","volume":"88","author":"Constantopoulos","year":"1985","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmcr.2021.101432_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1378\/chest.108.2.316","article-title":"Pulmonary findings in patients with primary Sjogren's syndrome","volume":"108","author":"Lahdensuo","year":"1995","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmcr.2021.101432_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2214\/ajr.169.3.9275871","article-title":"Primary Sjogren's syndrome and associated lung disease: CT findings in 50 patients","volume":"169","author":"Franquet","year":"1997","journal-title":"AJR Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101432_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.rmcr.2021.101432_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.rmcr.2021.101432_bib13","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.rmcr.2021.101432_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sjogren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.rmcr.2021.101432_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201508-1632OC","article-title":"In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011","volume":"193","author":"Hutchinson","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmcr.2021.101432_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ard.2004.030643","article-title":"Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.rmcr.2021.101432_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.rmcr.2021.101432_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","article-title":"Topical and systemic medications for the treatment of primary Sjogren's syndrome","volume":"8","author":"Ramos-Casals","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.rmcr.2021.101432_bib19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101432_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.2008.092601","article-title":"Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment","volume":"68","author":"Meijer","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.rmcr.2021.101432_bib21","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann. Rheum. Dis."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007121000940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007121000940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:04:01Z","timestamp":1761959041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007121000940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":21,"alternative-id":["S2213007121000940"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2021.101432","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sj\u00f6gren syndrome","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2021.101432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101432"}}